Pharmaron Beijing Co Ltd Working Capital to Net Assets Ratio
Pharmaron Beijing Co Ltd working capital to net assets ratio. Pharmaron Beijing Co Ltd (300759) has a Working Capital to Net Assets ratio of 17.3% as of September 2025. Working capital of CN¥2.62 Billion (current assets of CN¥7.81 Billion minus current liabilities of CN¥5.19 Billion) is measured against net assets of CN¥15.18 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pharmaron Beijing Co Ltd (2014–2024)
Working capital to net assets ratio of Pharmaron Beijing Co Ltd from 2014 to 2024. This chart shows how Pharmaron Beijing Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 17.3%, reflecting working capital of CN¥2.62 Billion against net assets of CN¥15.18 Billion CNY. See 300759 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Pharmaron Beijing Co Ltd Working Capital to Net Assets Ratio by Year (2014–2024)
Pharmaron Beijing Co Ltd working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Pharmaron Beijing Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Pharmaron Beijing Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 23.8% | CN¥3.38 Billion | CN¥14.22 Billion | CN¥7.61 Billion | CN¥4.22 Billion | ▼ -30.7 pp |
| 2023 | 54.5% | CN¥7.22 Billion | CN¥13.24 Billion | CN¥10.87 Billion | CN¥3.65 Billion | ▲ +30.3 pp |
| 2022 | 24.2% | CN¥2.62 Billion | CN¥10.84 Billion | CN¥6.54 Billion | CN¥3.91 Billion | ▼ -30.8 pp |
| 2021 | 55.0% | CN¥5.66 Billion | CN¥10.30 Billion | CN¥8.64 Billion | CN¥2.98 Billion | ▲ +15.2 pp |
| 2020 | 39.8% | CN¥3.56 Billion | CN¥8.93 Billion | CN¥5.54 Billion | CN¥1.98 Billion | ▼ -19.8 pp |
| 2019 | 59.6% | CN¥4.67 Billion | CN¥7.84 Billion | CN¥5.94 Billion | CN¥1.27 Billion | ▲ +58.6 pp |
| 2018 | 1.1% | CN¥24.85 Million | CN¥2.34 Billion | CN¥1.28 Billion | CN¥1.26 Billion | ▼ -5.8 pp |
| 2017 | 6.8% | CN¥137.16 Million | CN¥2.01 Billion | CN¥1.08 Billion | CN¥941.02 Million | ▼ -17.9 pp |
| 2016 | 24.7% | CN¥436.28 Million | CN¥1.76 Billion | CN¥1.10 Billion | CN¥660.88 Million | ▲ +339.5 pp |
| 2015 | -314.7% | CN¥-530.11 Million | CN¥168.43 Million | CN¥435.00 Million | CN¥965.11 Million | ▼ -222.1 pp |
| 2014 | -92.6% | CN¥-239.26 Million | CN¥258.25 Million | CN¥341.30 Million | CN¥580.56 Million | — |